Nephroplus Initiates Postal Ballot for Director Re-appointment and Auditor Appointment
Nephrocare Health Services Limited is conducting a postal ballot for shareholders to vote on the re-appointment of Mr. Om Prakash Manchanda as Independent Director and the appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditor. Remote e-voting is open from January 8, 2026, to February 6, 2026.
The announcement concerns standard corporate governance procedures like director re-appointment and auditor appointment, which are not expected to have a significant immediate impact on the company's operations, financials, or stock price.
The announcement pertains to routine corporate governance procedures, including the re-appointment of a director and the appointment of a secretarial auditor, which are standard practices and do not inherently indicate positive or negative performance or outlook.
Nephrocare Health Services Limited has initiated the process of dispatching a Postal Ballot Notice dated January 05, 2026, to its members via electronic mode. This action is in compliance with Sections 110 and 108 of the Companies Act, 2013, and related rules and SEBI regulations.
The notice, along with an Explanatory Statement, seeks approval from the shareholders through remote e-voting for two key business items. The first item is the re-appointment of Mr. Om Prakash Manchanda as an Independent Director, requiring a Special Resolution. The second item is the appointment of M/s Makarand M. Joshi & Co. as the Secretarial Auditor of the Company, requiring an Ordinary Resolution.
The remote e-voting facility is provided through National Securities Depository Limited (NSDL) and commenced on January 08, 2026, at 9:00 a.m. IST. The voting period will conclude on February 06, 2026, at 5:00 p.m. IST. Members holding shares as of the cut-off date, January 02, 2026, are eligible to vote. Ms. Rashida Hatim Adenwala has been appointed as the Scrutinizer for the Postal Ballot process.
The Postal Ballot Notice is available on the company's website (www.Nephroplus.com) and NSDL's e-voting website (www.evoting.nsdl.com). The results of the e-voting, along with the Scrutiniser's Report, will be declared on the company's and stock exchanges' websites within two working days of the e-voting closure.
What to do with a filing like this
Nephrocare Health Services Limited filed this with the NSE as a statutory disclosure, categorised under shareholder meetings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nephrocare Health Services Limited. Read the original for the full detail.